Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: BelowTheCrowd who wrote (8307)	5/4/1998 4:14:00 PM
From: Ploni	Respond to of 18691

Can angiostatin and endostatin be added to cigarettes, to eliminate the risk of getting cancer? Maybe the tobacco plants themselves can be genetically re-engineered, to add these compounds. :-)

To: BelowTheCrowd who wrote (8307)	5/4/1998 7:30:00 PM
From: George Acton	Read Replies (1) \| Respond to of 18691

Folkman has been working on this subject for 20 years, for a long time witout much recognition. It's generally agreed that his work is completely sound. I think he wrote it up for Scientific American a long time ago, when they used to have the world authority write a popular review of his work. The problem has been finding a practical way to prevent cancer cells from instructing the local blood vessels to proliferate and grow into the tumor. That they do send the local instructions is very clear, and if the cancer can't get a blood supply it can't grow enough to be a threat. The immediate catalyst is the NYT article. It has some exuberant quotes from people like Watson (a Good Guy who sometimes shoots from the hip). It worse than vague on when the key breakthrough experiments were conducted. It's also a little strange that they didn't call a press conference to announce. Perhaps the CEO or PR people preferred to make the front page of the Sunday Times rather than issue a press release. --George Acton